Check Cap

MBAI · NASDAQ

$2.07+$0.015 (+0.73%)TodayMarket closed ·
Prev close $2.05

About MBAI

Check-Cap Ltd. is a clinical stage medical diagnostics company, which engages in the development of ingestible imaging capsule systems for colorectal cancer screening. Check Cap Ltd develops C-Scan, a patient-friendly preparation-free test designed to detect polyps before they may transform into cancer to enable early intervention and cancer prevention. Its capsule-based screening technology aims to increase screening adherence worldwide. The system utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps and other structural abnormalities. C-Scan is a non-invasive capsule that is propelled through the gastrointestinal tract by natural motility. C-Scan is comprised of three main components: C-Scan Cap, an ingestible X-ray scanning capsule; C-Scan Track, three miniaturized patches worn on the patient’s back for integrated positioning, control and data recording; and C-Scan View, a proprietary software to process and represent 2D and 3D maps of the inner surface of the colon.

Employees
85
Headquarters
Isfiya, Haifa
Listed
Feb 19, 2015
Sector
Health Care
Industry
Health Care Equipment & Supplies

Leadership

Check Cap executives
NameTitleSince
Steven Hanley—2015
Alex Ovadia——
Dan Hilerowitz——
Mira Rosenzweig——
Yoav Kimchy—2005
Joshua Belkar——
Hanit Brenner-lavie——
Israel Hershko——
Boaz Shpigelman——
Clara Ezed——
Mary Jo Gorman——
XiangQian Lin——
Yuval Yanai——
Irina Koffler—2021

Similar companies

Companies in the same industry as Check Cap

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.